IL17A and alcoholic fatty liver disease: Not only is IL‐17 involved in alcoholic fatty liver disease, but has also been demonstrated to promote nonalcoholic fatty liver and nonalcoholic steatohepatitis, thus indicating that IL‐17 may contribute to MAFLD progression (Harley et al., 2014).